99-13692. Notice of Prospective Patent License

[Federal Register Volume 64, Number 104 (Tuesday, June 1, 1999)]
[Notices]
[Page 29363]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-13692]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice 99-068]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Prospective Patent License.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that New Century Pharmaceuticals, 
Inc., of Huntsville, Alabama, has applied for an exclusive license to 
practice the invention disclosed in NASA Case No. MFS-31320-1 entitled 
``Oxygen-Transportation Albumin-Based Blood Replacement Composition and 
Blood Volume Expander,'' for which a U.S. Patent Application was filed 
and assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. 
Written objections to the proposed grant of a license should be sent to 
Mr. James J. McGroary, Patent Counsel, Mail Code CC01, Marshall Space 
Flight Center, Huntsville, AL 35812.

DATES: Responses to this notice must be received by August 2, 1999.

FOR FURTHER INFORMATON CONTACT: Sammy Nabors, Mail Code CO30, Marshall 
Space Flight Center, Huntsville, AL 35803; telephone [phone].

    Dated: May 24, 1999.
Edward A. Frankle,
General Counsel.
[FR Doc. 99-13692 Filed 5-28-99; 8:45 am]
BILLING CODE 7510-01-P